Articles with "reply mini" as a keyword



Reply to Mini‐HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?

Sign Up to like & get
recommendations!
Published in 2019 at "Cancer"

DOI: 10.1002/cncr.32385

Abstract: DOI: 10.1002/cncr.32381, Published online July 10, 2019 in Wiley Online Library (wileyonlinelibrary.com) of blinatumomab (which does not include costs for hospitalization or the supportive care requirements associated with the mini-HCVD backbone or costs to administer… read more here.

Keywords: plus inotuzumab; hcvd plus; mini hcvd; blinatumomab ... See more keywords